Holen Sie sich die Stockscreener-App
68.80
0.87%
-0.50
Finanzdaten der Inhibrx Biosciences Inc-Aktie (INBX)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-09-30 | 2025-07-01 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
-
|
- | - | 0.10 | - |
Operating Expenses
|
33.81
|
- | 42.90 | 50.03 | 46.80 |
| Operating Income/Loss |
-33.81
|
- | -42.90 | -49.93 | -46.80 |
| Nonoperating Income/Loss |
-1.444
|
- | -0.41 | 2.063 | 2.933 |
| Income/Loss From Continuing Operations Before Tax |
23.04%
-35.26
|
-28.65 | -43.31 | -47.87 | -43.86 |
| Income Tax Expense/Benefit |
-
|
- | - | - | - |
| Income/Loss From Continuing Operations After Tax |
23.04%
-35.26
|
-28.65 | -43.31 | -47.87 | -43.86 |
|
Net Income/Loss
|
23.04%
-35.26
|
-28.65 | -43.31 | -47.87 | -43.86 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
15.48
|
- | 15.47 | 0.224 | 15.47 |
| Diluted Average Shares |
15.48
|
- | 15.47 | 0.163 | 15.47 |
| Basic Earnings Per Share |
-2.28
|
- | -2.80 | -5.03 | -2.84 |
| Diluted Earnings Per Share |
-2.28
|
- | -2.80 | -4.47 | -2.84 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
0.41%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):